Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1130256> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- Q1130256 subject Q7204516.
- Q1130256 subject Q8229476.
- Q1130256 subject Q9062040.
- Q1130256 abstract "Linsidomine (3-morpholinosydnonimine or SIN-1) is a vasodilator. It is a metabolite of the antianginal drug molsidomine and acts by releasing NO from the endothelial cells nonenzymatically. It also hyperpolarizes the cell membrane through influencing the sodium-potassium pump and thereby rendering it less responsive to adrenergic stimulation. Linsidomine injection at a dose of 1 mg produces usable erection in about 70% of patients and full erection in up to 50% of patients. Linsidomine does not appear to be associated with priapism.Linsidomine is neurotoxic and promotes oxidative stress on neurons. Linsidomine is a peroxynitrite-generating compound involved in the pathogenesis of neurodegenerative diseases.".
- Q1130256 atcPrefix "C01".
- Q1130256 atcSuffix "DX18".
- Q1130256 fdaUniiCode "5O5U71P6VQ".
- Q1130256 iupacName "5-imino-3-morpholin-4-yl-5H-1,2,3-oxadiazol-3-ium-2-ide".
- Q1130256 pubchem "5219".
- Q1130256 thumbnail Linsidomine_structure.svg?width=300.
- Q1130256 wikiPageWikiLink Q14859627.
- Q1130256 wikiPageWikiLink Q1755122.
- Q1130256 wikiPageWikiLink Q207843.
- Q1130256 wikiPageWikiLink Q408132.
- Q1130256 wikiPageWikiLink Q419130.
- Q1130256 wikiPageWikiLink Q7204516.
- Q1130256 wikiPageWikiLink Q8229476.
- Q1130256 wikiPageWikiLink Q898814.
- Q1130256 wikiPageWikiLink Q9062040.
- Q1130256 atcPrefix "1.0".
- Q1130256 atcSuffix "DX18".
- Q1130256 iupacName "5".
- Q1130256 pubchem "5219".
- Q1130256 unii "5".
- Q1130256 type ChemicalSubstance.
- Q1130256 type Drug.
- Q1130256 type ChemicalObject.
- Q1130256 type Thing.
- Q1130256 type Q8386.
- Q1130256 comment "Linsidomine (3-morpholinosydnonimine or SIN-1) is a vasodilator. It is a metabolite of the antianginal drug molsidomine and acts by releasing NO from the endothelial cells nonenzymatically. It also hyperpolarizes the cell membrane through influencing the sodium-potassium pump and thereby rendering it less responsive to adrenergic stimulation. Linsidomine injection at a dose of 1 mg produces usable erection in about 70% of patients and full erection in up to 50% of patients.".
- Q1130256 label "Linsidomine".
- Q1130256 depiction Linsidomine_structure.svg.